Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Reckitt Benckiser to invest $200 million in UK, U.S. units this year

Published 04/06/2019, 15:24
Updated 04/06/2019, 15:24
© Reuters. FILE PHOTO: Rakesh Kapoor, the CEO of Reckitt Benckiser, poses for a photograph at the company headquarters in Slough

© Reuters. FILE PHOTO: Rakesh Kapoor, the CEO of Reckitt Benckiser, poses for a photograph at the company headquarters in Slough

By Siddharth Cavale

(Reuters) - Dettol and Lysol maker Reckitt Benckiser Group Plc (LON:RB) will invest an additional $200 million in its UK and U.S. units this year, including a $70 million investment in a Michigan manufacturing facility.

Chief Executive Officer Rakesh Kapoor said the funds would be used to expand the company's Michigan plant, which was bought as part of its takeover of Enfamil infant formula maker Mead Johnson Nutrition company for about $18 billion in 2017. He gave no further details.

Kapoor made his remarks at a breakfast event at St James' Palace, the Queen's official residence, attended by U.S. President Donald Trump and high level executives from 10 U.S. and British businesses.

The CEO, who will retire at the end of this year, said the company has made significant investments in both countries, creating high level scientific jobs. The company employs about 10 percent of its 40,000 workforce in the U.S. and the United Kingdom.

Kapoor said the Harpic maker was also working with UK and U.S. regulatory authorities to find ways to provide wider and easier access to healthcare.

The company is partnering with Walmart (NYSE:WMT) Inc and Health 4 All to offer telehealth vouchers to the U.S. retailer's customers allowing them to get free consultations from home.

© Reuters. FILE PHOTO: Rakesh Kapoor, the CEO of Reckitt Benckiser, poses for a photograph at the company headquarters in Slough

Reckitt Benckiser's shares were flat in afternoon trading on the London Stock Exchange.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.